Viemed Healthcare, Inc. - Laporan Laba Rugi (TTM)

Viemed Healthcare, Inc.
US ˙ NasdaqCM ˙ CA92663R1055

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Viemed Healthcare, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 122 131 136 120 116 117 121 127 133 139 146 156 170 183 194 206 214 224 233 241
Change (%) 8.02 3.51 -11.37 -3.45 0.65 3.28 4.89 5.11 4.16 5.26 6.84 8.74 7.79 6.03 6.01 4.18 4.65 3.81 3.48
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 46 51 54 46 43 44 45 49 52 54 57 61 66 70 75 80 85 91 96 100
Change (%) 10.39 4.73 -13.34 -6.65 0.64 4.21 6.92 6.59 4.46 5.61 7.49 7.70 6.07 7.46 6.45 5.97 6.97 5.56 4.42
% of Revenue 38.15 38.99 39.45 38.57 37.30 37.29 37.63 38.35 38.89 39.01 39.14 39.37 39.00 38.37 38.89 39.05 39.72 40.60 41.29 41.67
Gross Operating Profit 75 80 82 74 73 73 75 78 81 85 89 95 104 113 119 125 129 133 137 141
Change (%) 6.56 2.73 -10.09 -1.45 0.66 2.73 3.67 4.18 3.97 5.03 6.43 9.41 8.90 5.14 5.72 3.04 3.12 2.61 2.81
% of Revenue 61.85 61.01 60.55 61.43 62.70 62.71 62.37 61.65 61.11 60.99 60.86 60.63 61.00 61.63 61.11 60.95 60.28 59.40 58.71 58.33
SG&A 55 58 62 58 58 60 61 66 70 73 77 80 86 93 98 104 108 112 117 120
Change (%) 4.51 7.08 -5.67 -0.38 3.39 2.11 7.65 6.70 4.18 5.55 3.78 7.40 7.98 5.35 6.28 3.30 4.03 4.03 2.73
% of Revenue 45.43 43.95 45.47 48.39 49.93 51.29 50.71 52.04 52.83 52.84 52.99 51.47 50.83 50.92 50.60 50.73 50.30 50.00 50.11 49.75
R&D 1 1 1 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 3 3
Change (%) 21.55 15.24 25.00 21.35 11.46 13.89 3.70 3.77 4.25 5.49 3.02 -2.63 -2.49 -1.08 0.00 5.96 5.21 1.53 2.86
% of Revenue 0.73 0.82 0.92 1.29 1.63 1.80 1.99 1.97 1.94 1.94 1.95 1.88 1.68 1.52 1.42 1.34 1.36 1.37 1.34 1.33
OpEx 103 110 117 107 104 107 109 117 125 130 138 146 156 167 178 189 197 207 217 224
Change (%) 6.91 6.09 -8.86 -2.80 2.71 2.76 7.16 6.63 4.27 5.84 5.49 7.38 7.11 6.22 6.06 4.29 5.19 4.59 3.59
% of Revenue 84.92 84.04 86.14 88.58 89.18 91.01 90.55 92.51 93.85 93.95 94.47 93.27 92.11 91.52 91.69 91.73 91.83 92.31 93.01 93.11
Operating Income 18 21 19 14 13 11 11 9 8 8 8 11 13 16 16 17 18 17 16 17
Change (%) 14.29 -10.09 -26.95 -8.57 -16.32 8.57 -16.90 -13.72 2.48 -3.83 30.05 27.61 15.74 3.96 5.42 3.00 -1.50 -5.62 1.97
% of Revenue 15.08 15.96 13.86 11.42 10.82 8.99 9.45 7.49 6.15 6.05 5.53 6.73 7.89 8.48 8.31 8.27 8.17 7.69 6.99 6.89
Interest Expense -1 -1 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1
Change (%) -18.04 -13.16 -11.76 -10.51 -8.88 -8.49 -8.25 -12.36 -15.81 -32.49 -44.36 170.27 112.00 35.38 44.25 6.88 -12.32 3.74 -15.16
% of Revenue -0.51 -0.39 -0.33 -0.32 -0.30 -0.27 -0.24 -0.21 -0.18 -0.14 -0.09 -0.05 -0.12 -0.23 -0.30 -0.40 -0.41 -0.35 -0.35 -0.28
Net Income 29 32 29 11 10 9 9 9 8 6 6 7 9 10 10 9 10 11 12 14
Change (%) 9.30 -8.12 -61.60 -9.12 -9.73 0.85 -6.51 -8.53 -20.95 -3.94 22.80 25.40 11.29 0.84 -8.35 10.13 8.05 9.07 13.75
% of Revenue 23.73 24.01 21.31 9.24 8.69 7.80 7.61 6.79 5.91 4.48 4.09 4.70 5.42 5.60 5.32 4.60 4.87 5.02 5.28 5.80

Source: Capital IQ

Other Listings
DE:VIJ € 5.55
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista